Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells
Crossref DOI link: https://doi.org/10.1007/978-1-0716-2010-6_10
Published Online: 2022-02-25
Published Print: 2022
Update policy: https://doi.org/10.1007/springer_crossmark_policy
López-Márquez, Arístides
Martínez-Pizarro, Ainhoa
Pérez, Belén
Richard, Eva
Desviat, Lourdes R. http://orcid.org/0000-0002-2081-0815
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-01-01
Version of Record valid from 2022-02-25
Chapter History
First Online: 25 February 2022